Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Combination Chemotherapy in AIDS-Related Non-Hodgkin's Lymphoma
NCT00049439Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Mar 1998
- Primary completion
- Oct 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 2 trial of lomustine, etoposide, cyclophosphamide, procarbazine in AIDS-related non-Hodgkin lymphoma (ARL), sponsored by Case Comprehensive Cancer Center. Started Mar 1998; status: completed.
02
Drugs
lomustineetoposidecyclophosphamideprocarbazine
03
Conditions
AIDS-related non-Hodgkin lymphoma (ARL)
Beyond the preview
Go deeper on NCT00049439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049439.